oncolytic adenovirus expressing interferon beta/CD40 ligand MEM-288
Term · Oncology and biomedicine · MLC-T-ONC-015628
A conditionally replicative, oncolytic adenovirus that has been genetically engineered to encode the transgenes for the human cytokine interferon beta (IFN-beta) and MEM40, a recombinant, chimeric form of CD40 ligand (CD40L), with potential immunostimulating and antineoplastic activities. Upon intratumoral administration, the oncolytic adenovirus expressing IFN-beta/CD40L MEM-288 selectively infects and replicates in tumor cells, leading to tumor cell lysis. In addition, the IFN-beta expressed by the oncolytic adenovirus activates T lymphocytes, dendritic cells (DCs) and natural killer (NK) cells, and induces an anti-tumor immune response against the tumor cells. The CD40L expressed by the oncolytic adenovirus specifically binds to and activates CD40, a cell surface receptor that belongs to the tumor necrosis factor (TNF) receptor family and is expressed on various immune cells, such as B lymphocytes, monocytes, and DCs. Activation of CD40 induces proliferation and activation of B lymphocytes, shifts the induction of immunosuppressive macrophages towards immunostimulatory macrophages, activates monocyte-derived DCs (moDCs) and leads to the secretion of inflammatory cytokines. This activates the immune system to mount a cytotoxic T-lymphocyte (CTL) immune response against tumor cells.
| Identifier | MLC-T-ONC-015628 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | oncolytic adenovirus expressing IFN-beta/CD40L MEM-288; oncolytic adenovirus expressing human interferon beta and recombinant CD40 ligand MEM-288; oncolytic adenovirus expressing IFN-beta/MEM40 MEM-288; interferon beta/chimeric CD40 ligand-encoding adenovirus vector MEM-288; IFN-beta and chimeric CD40 ligand-encoding adenovirus vector MEM-288 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015628",
"term": "oncolytic adenovirus expressing interferon beta/CD40 ligand MEM-288",
"field": "Oncology and biomedicine",
"definition": "A conditionally replicative, oncolytic adenovirus that has been genetically engineered to encode the transgenes for the human cytokine interferon beta (IFN-beta) and MEM40, a recombinant, chimeric form of CD40 ligand (CD40L), with potential immunostimulating and antineoplastic activities. Upon intratumoral administration, the oncolytic adenovirus expressing IFN-beta/CD40L MEM-288 selectively infects and replicates in tumor cells, leading to tumor cell lysis. In addition, the IFN-beta expressed by the oncolytic adenovirus activates T lymphocytes, dendritic cells (DCs) and natural killer (NK) cells, and induces an anti-tumor immune response against the tumor cells. The CD40L expressed by the oncolytic adenovirus specifically binds to and activates CD40, a cell surface receptor that belongs to the tumor necrosis factor (TNF) receptor family and is expressed on various immune cells, such as B lymphocytes, monocytes, and DCs. Activation of CD40 induces proliferation and activation of B lymphocytes, shifts the induction of immunosuppressive macrophages towards immunostimulatory macrophages, activates monocyte-derived DCs (moDCs) and leads to the secretion of inflammatory cytokines. This activates the immune system to mount a cytotoxic T-lymphocyte (CTL) immune response against tumor cells.",
"synonyms": [
"oncolytic adenovirus expressing IFN-beta/CD40L MEM-288",
"oncolytic adenovirus expressing human interferon beta and recombinant CD40 ligand MEM-288",
"oncolytic adenovirus expressing IFN-beta/MEM40 MEM-288",
"interferon beta/chimeric CD40 ligand-encoding adenovirus vector MEM-288",
"IFN-beta and chimeric CD40 ligand-encoding adenovirus vector MEM-288"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/oncolytic-adenovirus-expressing-interferon-beta-cd40-ligand-mem-288/"
}
Record 12,191 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.